Landscapes / Targets
IRAK
7 drugs act on IRAK, in 10 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs7
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Kinase inhibitor |
Approved | 30 Dec 2026Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 30 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Low Risk Myelodysplastic Syndromes | ||||
| Open drug page | |||||
— |
Phase 2 | Jan 2028Phase 2 trial completes | |||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS) | ||||
| Open drug page | |||||
Pacritinibnot checked |
Kinase inhibitor |
Phase 2 | Jul 2028Phase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Leukemia, Myelomonocytic, Chronic | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2027Phase 1 trial completes | |||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Relapsed and Refractory Acute Myeloid Leukemia (RR-AML) | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1 | 20 Oct 2028Phase 1 trial completes | ||
| Next date | 20 Oct 2028 · Phase 1 trial completes | ||||
| Also tested for | Haematologic Neoplasms | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | AML With Gene Mutations | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026